254 related articles for article (PubMed ID: 15620654)
61. Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2.
Lillard-Wetherell K; Machwe A; Langland GT; Combs KA; Behbehani GK; Schonberg SA; German J; Turchi JJ; Orren DK; Groden J
Hum Mol Genet; 2004 Sep; 13(17):1919-32. PubMed ID: 15229185
[TBL] [Abstract][Full Text] [Related]
62. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
63. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
64. Telomere dysfunction and chromosome structure modulate the contribution of individual chromosomes in abnormal nuclear morphologies.
Pampalona J; Soler D; Genescà A; Tusell L
Mutat Res; 2010 Jan; 683(1-2):16-22. PubMed ID: 19822157
[TBL] [Abstract][Full Text] [Related]
65. Functional interplay between SA1 and TRF1 in telomeric DNA binding and DNA-DNA pairing.
Lin J; Countryman P; Chen H; Pan H; Fan Y; Jiang Y; Kaur P; Miao W; Gurgel G; You C; Piehler J; Kad NM; Riehn R; Opresko PL; Smith S; Tao YJ; Wang H
Nucleic Acids Res; 2016 Jul; 44(13):6363-76. PubMed ID: 27298259
[TBL] [Abstract][Full Text] [Related]
66. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.
Bellon M; Datta A; Brown M; Pouliquen JF; Couppie P; Kazanji M; Nicot C
Int J Cancer; 2006 Nov; 119(9):2090-7. PubMed ID: 16786598
[TBL] [Abstract][Full Text] [Related]
67. Distinct roles of TRF1 in the regulation of telomere structure and lengthening.
Okamoto K; Iwano T; Tachibana M; Shinkai Y
J Biol Chem; 2008 Aug; 283(35):23981-8. PubMed ID: 18587156
[TBL] [Abstract][Full Text] [Related]
68. TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres.
d'Alcontres MS; Palacios JA; Mejias D; Blasco MA
Cell Cycle; 2014; 13(9):1463-81. PubMed ID: 24626180
[TBL] [Abstract][Full Text] [Related]
69. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
70. TRF2 protects human telomeres from end-to-end fusions.
van Steensel B; Smogorzewska A; de Lange T
Cell; 1998 Feb; 92(3):401-13. PubMed ID: 9476899
[TBL] [Abstract][Full Text] [Related]
71. Telomere dysfunction and chromosome instability.
Murnane JP
Mutat Res; 2012 Feb; 730(1-2):28-36. PubMed ID: 21575645
[TBL] [Abstract][Full Text] [Related]
72. Pot1, the putative telomere end-binding protein in fission yeast and humans.
Baumann P; Cech TR
Science; 2001 May; 292(5519):1171-5. PubMed ID: 11349150
[TBL] [Abstract][Full Text] [Related]
73. Cell-cycle-dependent regulation of telomere binding proteins: roles of Polo-like kinase.
Nishiyama A; Ishikawa F
Cell Cycle; 2006 Jul; 5(13):1403-6. PubMed ID: 16855394
[TBL] [Abstract][Full Text] [Related]
74. Novel anticancer strategy aimed at targeting shelterin complexes by the induction of structural changes in telomeric DNA: hitting two birds with one stone.
Bidzinska J; Baginski M; Skladanowski A
Curr Cancer Drug Targets; 2014; 14(2):201-16. PubMed ID: 24443969
[TBL] [Abstract][Full Text] [Related]
75. PRL-3 promotes telomere deprotection and chromosomal instability.
Lian S; Meng L; Yang Y; Ma T; Xing X; Feng Q; Song Q; Liu C; Tian Z; Qu L; Shou C
Nucleic Acids Res; 2017 Jun; 45(11):6546-6571. PubMed ID: 28482095
[TBL] [Abstract][Full Text] [Related]
76. A siRNA-based screen for genes involved in chromosome end protection.
Lackner DH; Durocher D; Karlseder J
PLoS One; 2011; 6(6):e21407. PubMed ID: 21760879
[TBL] [Abstract][Full Text] [Related]
77. Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas.
Begemann S; Galimi F; Karlseder J
Aging (Albany NY); 2009 Jan; 1(1):122-130. PubMed ID: 20046894
[TBL] [Abstract][Full Text] [Related]
78. A quantitative assay for telomere protection in Saccharomyces cerevisiae.
DuBois ML; Haimberger ZW; McIntosh MW; Gottschling DE
Genetics; 2002 Jul; 161(3):995-1013. PubMed ID: 12136006
[TBL] [Abstract][Full Text] [Related]
79. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
[TBL] [Abstract][Full Text] [Related]
80. A small molecule inhibitor of Pot1 binding to telomeric DNA.
Altschuler SE; Croy JE; Wuttke DS
Biochemistry; 2012 Oct; 51(40):7833-45. PubMed ID: 22978652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
